Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2018 Nov 29;9:1387. doi: 10.3389/fphar.2018.01387

Corrigendum: Mequindox Induced Genotoxicity and Carcinogenicity in Mice

Qianying Liu 1,2, Zhixin Lei 1, Qin Wu 1, Deyu Huang 1, Shuyu Xie 1,3, Xu Wang 1,3, Yuanhu Pan 1,3,*, Zonghui Yuan 1,2,3,4,*
PMCID: PMC6283233  PMID: 30546310

In the original article, there was a mistake in Figures 5B,F as published. The descriptions of Figures 5B,F did not match the figures displayed. The corrected Figure 5 appears below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Figure 5.

Figure 5

Selected microphotographs of kidney, liver and testis following dietary exposure to MEQ in the carcinogenicity tests (200×, 400×). (A) Kidney from control group (200×); (B) Kidney from the M25 mg/kg group showing kidney interstitial small blood vessels congestion, glomerular congestion (400×); (C) Kidney from the M55 mg/kg group showing aggregation of lymphocyte into a group around the central veins (200×); (D) Kidney from the M110 mg/kg group showing degeneration and necrosis of renal tubular epithelial cells (400×); (E) Liver from control group (200×); (F) Liver from the M25 mg/kg group showing degeneration and necrosis of hepatic cells (400×); (G) Liver from the M55 showing neutrophilic infiltrate within and around bile duct (200×); (H) Liver from the M110 mg/kg group showing proliferation in bile duct epithelium (200×); (I) Testis from the control group (400×); (J) Testis from the M25 mg/kg group showing a broadened testicular interstitium (400×); (K) Testis at the M55 mg/kg group showing an irregular arrangement as well as a decreased number of spermatogenic cells (200×); (L) Testis at the M110 mg/kg group showing necrosis of spermatogonia and spermatocytes in the lumen (200×).

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES